🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chimene Kesserwan

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0001-6043-2065
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Cell Death and Differentiation(2022)10.1038/s41418-022-00976-3
Top 6%
4.0DataRank
Top 6%167 citations

Elaine E. Lee, Elise M. Tookmanian, Chimene Kesserwan, James J. Manfredi, Jessica N. Hatton +12 more

Papers

Driven by 10 papers — median percentile 87. Top paper: “The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute”.

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Cell Death and Differentiation(2022)10.1038/s41418-022-00976-3
Top 6%
4.0DataRank
Top 6%167 citations

Elaine E. Lee, Elise M. Tookmanian, Chimene Kesserwan, James J. Manfredi, Jessica N. Hatton +12 more

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979
Top 19%
1.0DataRank
Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines

Journal of Medical Genetics(2022)10.1136/jmg-2022-108807
N/A
0.745DataRank · unranked
24 citations

Jamie L. Maciaszek, Bryony A. Thompson, Huei San Leong, Katherine Dixon, Sónia Sousa +19 more

Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas

Cancers(2021)10.3390/cancers13236092
N/A
0.533DataRank · unranked
34 citations

Ying Pang, Mythili Merchant, Chimene Kesserwan, Vineela Gangalapudi, Abdalla Abdelmaksoud +15 more

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100938
N/A
0.500DataRank · unranked
27 citations

Qun Jiang, Jun S. Wei, Vikram Misra, Betsy Morrow, Chimene Kesserwan +11 more

A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome

Genome Medicine(2025)10.1186/s13073-025-01536-3
N/A
0.269DataRank · unranked
5 citations

Megan N. Frone, Jessica L. Mester, Miguel de la Hoya, Phuong L. Mai, Tina Pesaran +32 more

A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4607
N/A
0.208DataRank · unranked
3 citations

Nicholas I. Simon, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Rouf Banday +15 more

Transcriptomics based prediction of survival and response to therapy in malignant mesothelioma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.13.488207
N/A
0DataRank · unranked
1 citations

Qun Jiang, Jun S. Wei, Vikram Misra, Betsy Morrow, Chimene Kesserwan +10 more

ClinGen CDH1 specifications for the ACMG/AMP guidelines: improvement of germline variant clinical assertions and updated curation guidelines

medRxiv(2021)10.1101/2021.11.01.21265332
N/A
0DataRank · unranked
0 citations

Jamie L. Maciaszek, Bryony A. Thompson, Huei San Leong, Katherine Dixon, Sónia Sousa +19 more

How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies

Haematologica(2020)10.3324/haematol.2018.214221
N/A
0DataRank · unranked
32 citations

Xi Luo, Simone Feurstein, Chimene Kesserwan, Shruthi Mohan, Daniel Pineda‐Alvarez +2 more